INTRODUCTION
interleukin (il)-6 family cytokines are indispensable to liver regeneration. The Janus kinase/signal transducers and activators of transcription (JAK/STAT3) pathway is thought to play the central role in signal transduction mediated by il-6 family. Several target genes of STAT3 have been identified; these genes include cyclin D, c-myc, bcl-xL, and mcl-1, which are essential for cell proliferation and survival. in murine models of liver injury, ablation of STAT3 in liver results in enhanced liver injury and reduced liver regeneration [1] . These findings suggest the protective and proliferative roles of STAT3 in liver regeneration. in addition, STAT3 has been implicated in cellular differentiation, and its activation is associated with differentiation of T cells and macrophages [2] . Studies have demonstrated that STAT3 is essential for the maintenance of pluripotency of embryonic stem (ES) cells [3, 4] and self-renewal of tumor-initiating cells in the liver [5] . However, the differentiative role of STAT3 in liver regeneration is questionable.
Both cholangiocytes and hepatocytes are derived from hepatoblasts generated in the foregut endoderm during liver development. The bipotential hepatobiliary stem/progenitor cells, such as small hepatocytes and oval cells, have been shown to exist in adult liver and are thought to contribute to liver regeneration [6] . On the other hand, previous reports have revealed direct transdifferentiation between hepatocytes and cholangiocytes in chronic liver damage [7, 8] . Cholangiocytes transdifferentiate into hepatocytes and replenish massive hepatocyte loss [9] . in reverse, cholangiocytes were shown to be generated from transdifferentiating hepatocytes during biliary injury [10] . These evidences suggest that both mature cholangiocytes and hepatocytes play complimentary roles to promote liver regeneration through transdifferentiation. Sex determining region Y-box9 (SOX9), required for the normal differentiation of the biliary tract, is primarily expressed in mature cholangiocytes. However, weak expression of SOX9 was also observed in a small population of hepatocytes, which may display the potential to transdifferentiate into cholangiocytes [11] . Otherwise, cellular fate in the liver is regulated by Yes-associated protein (YAP), an important effector of Hippo pathway [12, 13] . YAP depletion in the liver is characterized by cholangiocytes proliferation after biliary obstruction [14] . in contrast, YAP activation in hepatocytes results in their transdifferentiation into cholangiocytes, leading to over-growth of atypical ductal cells -a process termed as atypical ductular reaction [12] . By interacting with TEAD transcription factor, YAP induces the expression of target genes, including Notch2 [15] . NOTCH2 signaling, in turn, induces the expression of its target genes SOX9 [12] . Therefore, YAP/SOX9 axis promotes transdifferentiation of hepatocytes into cholangiocytes. However, the mechanism underlying the regulation of YAP/SOX9 axis activation in hepatocytes needs to be elucidated.
To investigate if STAT3 is implicated in hepatocyte proliferation and differentiation in liver injury, we evaluated thioacetamide (TAA)-induced hepatocarcinogenesis and hepatocyte transdifferentiation in mouse with STAT3-deficient liver. STAT3-deficient liver showed profound ductular proliferation with upregulated YAP/SOX9 expression in hepatocytes. Our study indicates that STAT3 regulates transdifferentiation of hepatocytes into biliary cells.
MATERIALS AND METHODS

Mice
Mice were hosted in the cage whose dimension is 218 mm × 320 mm × 133 mm, in which recycled paper bedding and enrichment that stimulates natural instincts were put, and had free access to water and a standard rodent diet during the experimental period. All mice were maintained under specific pathogenfree conditions, and were monitored every other day. We observed any signs of abnormalities (i.e. marked weight loss or behavior change), but no mice became ill or died prior to the experimental end point. All mice experiments were conducted in strict accordance with the NiH Guidelines for the Care and Use of laboratory Animals and were approved by the University of Kurume institutional Animal Care and Use Committee. Albumin-Cre (Alb-Cre) mice on a C57/ Bl6 background expressing Cre recombinase under the control of the mouse albumin gene regulatory region and STAT3 flox/flox mice on a C57/Bl6 background were prepared previously described [16] . 
Quantitative real-time PCR
Total RNA was isolated using the TRiZOl Reagent l (invitrogen, Carlsbad, CA, United States) and reverse transcription was performed using Superscript Ⅲ (invitrogen). Real time PCR was carried out using SYBR TAA-induced liver injury ( Figure 2A ). PCNA positive hepatocytes were significantly decreased in STAT3 Δhep mice ( Figure 2A and B), indicative of the proliferative role of hepatic STAT3 in TAA-induced liver injury. Compensatory proliferation triggered by hepatocyte loss leads to not only liver regeneration but also development of HCC. Therefore, we next examined whether TAAinduced HCC development was inhibited in STAT3 Δhep mice. TAA treatment for thirty-week developed liver tumors which were histologically consistent with welldifferentiated HCC with no evident cholangiocellular carcinoma ( Figure 2C ). The liver tumor formations of STAT3 Δhep mice were significantly lesser than those of control mice ( Figure 2D ). These findings suggested that STAT3 was required, at least in part, for compensatory hepatocyte proliferation leading to HCC development.
Hepatic STAT3 deficiency accelerated TAA-induced biliary ducts and ductular structure formation
Hepatic necroinflammatory change induces atypical ductular reaction, which is characterized by proliferation of ductular cells. TAA treatment caused the biliary duct/ductular structure formation especially around periportal area ( Figure 3A ). To confirm the characteristics of bile duct/ductular cells, we performed immunohistochemical staining for KRT19, a marker of mature cholangiocytes. Most of ducts/ductular cells were immunoreactive for KRT19 ( Figure 3B ). 
STAT3 deficient hepatocytes showed upregulated SOX9 expression following TAA-induced liver injury
The formation of ducts/ductular structures has been thought to be attributable to both proliferation of mature cholangiocytes and biliary transdifferention of hepatocytes. To examine the origin of bile ducts/ductular structures, we next performed immunohistochemical staining for SOX9, because SOX9 is expressed in cholangiocytes and bipotential hepatobiliary cells [11] . As shown Figure 4A , the bile ducts/ductular structures were frequently composed of SOX9-positive cells. The number of SOX9-positive bile ducts/ductules of STAT3 Δhep mice was higher than that of control mice ( Figure 4B 
Statistical analysis
Statistical significance was assessed using the MannWhitney U-test. P < 0.05 was considered statistically significant. The data were presented as mean ± SE.
RESULTS
Hepatic STAT3 deficiency enhanced necroinflammatory change
To examine the protective role of STAT3 in hepatocytes, we first examined whether hepatic-STAT3 deficiency promoted TAA-induced liver injury. 
Hepatic STAT3 deficiency suppressed hepatocyte proliferation and HCC development
To elucidate the proliferative role of STAT3, we next examined whether TAA-induced hepatocytes regeneration was attenuated in STAT3 Δhep mice. immunohistochemical staining for proliferating cell nuclear antigen (PCNA) showed compensatory proliferation of hepatocytes in augmented in STAT3-deficient hepatocytes ( Figure 4C ).
YAP was activated in STAT3-deficient hepatocytes following TAA-induced liver injury
We next performed quantitative RT-PCR analysis to determine whether SOX9 expression was regulated at transcriptional level. TAA treatment upregulated the level of SOX9 mRNA expression, which was significantly increased in the liver of STAT3 Δhep mice compared to that of control (TAA 16 wk) ( Figure  5A ). immunoblot analysis confirmed higher levels of SOX9 expression in the liver of STAT3 Δhep mice ( Figure 5B ). in accordance with the marked bile duct/ ductular cell proliferation, the liver of STAT3 Δhep mice showed robust up-regulation of KRT19 expression at transcriptional and protein level. Although il-33 is a YAP mRNA expression in the liver of STAT3 Δhep mice was slightly higher than that of control mice. However, YAP protein expression was markedly increased in the liver of STAT3 Δhep mice. Previously, it was shown that src-family kinase induced-YAP tyrosine (Y357) phosphorylation leads to its stabilization and nuclear localization, activating its transcriptional property [17] . 
DISCUSSION
in this study, we show that STAT3-deficient liver displayed reduced HCC development and promoted biliary ductular proliferation during TAA-induced liver injury. STAT3-deficient hepatocytes exhibited YAP activation and upregulation of SOX9 expression, indicating transdifferentiation of hepatocytes into cholangiocytes. This study is the first report that STAT3 is implicated in both proliferation and differentiation of hepatocytes after liver injury. il-6 family cytokines are obviously essential for liver repair. il-6-deficiency impairs liver regeneration and causes liver failure characterized with blunted DNA synthesis in hepatocytes but not in nonparenchymal cells [18] . The role of JAK/STAT3 pathway has been extensively evaluated and thought to be essential for il-6-mediated liver repair, because STAT3 regulates many of genes associated with cell survival and proliferation. During liver regeneration after partial hepatectomy, hepatocytes-STAT3 activation was observed in periportal area [19] , which might harbor putative stem cell nische [20] . Recently, periportal hepatocytes were shown to have extensive proliferative property for liver repair [11] . These reports suggested that STAT3 activation in periportal area was crucial for liver regeneration. indeed, TAA-induced liver damage was augmented in liver specific STAT3-deficient mice compared to control mice. However, hepatic STAT3 deficiency did not cause lethal liver injury after TAA treatment. Consistently, previous reports showed that hepatic STAT3 deficiency, unlike il-6 deficiency, caused modest reduction of liver regeneration with no liver failure after partial hepatectomy [1] . These findings suggest that hepatic STAT3 plays a part of IL-6-mediated liver repair property. Because il-6 family cytokines activate ERK/MAPK and Pi3K/Akt pathways as well as JAK/STAT3 pathway through its receptor gp130, these pathways may lead to compensation of proliferation in STAT3-deficient hepatocytes. Until recently, YAP has been shown to regulate cell proliferation in some organs including liver [21] . By binding to TEAD transcription factor in nucleus, YAP activates expression of multiple genes including CTGF, CCND1 and BCL2L1 responsible for cell proliferation, antiapoptosis and survival. in Hippo/lats pathway, YAP serine (S127) phosphorylation results in cytoplasmic sequestration and inhibition of its transcriptional coactivator activity [22, 23] . in contrast, src-family kinase induced-YAP tyrosine (Y357) phosphorylation leads to its stabilization and nuclear localization, activating its transcriptional property [17] . Recent report revealed that il-6-mediated YAP tyrosine (Y357) phosphorylation via a gp130-src family kinase module promotes intestinal epithelial proliferation in vivo [24] . Therefore, YAP and STAT3 cooperatively might promote hepatocytes proliferation and survival for il-6-mediated liver regeneration. Compensatory YAP activation probably due to il-6 upregulation might restore the property of STAT3-deficient hepatocytes proliferation and survival. Recently il-22 has also been shown to be critical for liver regeneration [25] . Although il-22 does not interact gp130, il-22 receptor bind SHP2 leading to activation of both src family kinase and STAT3 [26] . YAP and STAT3 might be involved in not only il-6-mediated but il-22-mediated liver regeneration.
in addition to the role of cell proliferation and survival, YAP sustains undifferentiated state and pluripotency through regulating expression of stemnessassociated genes such as Oct4, Sox2 and Nanog [13] . YAP is overexpressed in cultured ES cells and may be required for self-renewal and suppression of differentiation [27] . YAP activation was shown to dedifferentiate mature hepatocytes into hepatobiliary progenitor cells [12] . SOX9-positive periportal hepatocytes display high regenerative property and were shown to self-renew and transdifferentiate into cholangiocytes [11] . it is interesting that SOX9 expression is upregulated by YAP activation through NOTCH pathway [12] . Therefore, activation of YAP/SOX9 axis is critical for hepatocyte dedifferentiation to accomplish liver repair. However, the regulation of YAP/ SOX9 axis activation in hepatocytes is still unknown. in this study, we found that STAT3 deficiency enhanced YAP tyrosine (Y357) phosphorylation and SOX9 expression through Src activation during TAA-induced liver injury. These findings suggest that STAT3 may inhibit dedifferentiation and transdifferentiation of hepatocytes by preventing the activation of YAP/SOX9 axis.
Demetris et al [28] previously reported that KRT19 positive/AFP negative hepatocytes, called ductular hepatocytes, appeared to exhibit ductular reaction in submassive liver necrosis. The ductular hepatocytes were thought to contribute to biliary repair through transdifferentiation into cholangiocytes.
As AFP synthesis and secretion were derived from differentiated hepatocytes in liver injury, TAA treatment upregulated AFP expression reflecting hepatocytes repopulation. The TAA treatment-induced AFP upregulation was significantly inhibited in hepatic-STAT3 deficient mice, whereas the expression of KRT19 was upregulated compared to control mice. interestingly, AFP expression is suppressed by YAP in undifferentiated ES cells, and YAP inhibition results in AFP expression with differentiation of ES cell [27] . These findings suggest that YAP activation in STAT3-deficient hepatocytes might direct their transdifferentiation into cholangiocytes instead of their dedifferentiation into progenitor cells. An important question is whether YAP activation in STAT3-deficient hepatocytes contribute to development of liver cancer, as YAP has been found to be involved in cholangiocarcinoma [29] . However, hepatic-STAT3 deficient mice did not cause cholangiocarcinoma, suggesting that STAT3 deficiencyinduced YAP activation is insufficient for oncogenic transformation at least in the model of TAA-induced liver injury. Otherwise, hepatic STAT3 depletion promoted fibrotic regeneration in TAA-induced liver injury model. Recent report showed that YAP expression was positively correlated with liver fibrosis in non-alcoholic steatohepatitis [30] . Because YAP has also been found to promote epithelial-mesenchymal transition [31] , the possibility is not excluded that YAP activation might promote transdifferentiation of hepatocytes into myofibroblast leading to liver fibrosis.
in conclusion, STAT3 is not only involved in HCC development but also prevents biliary ductular formation in TAA-induced liver injury. Our study highlights hepatic STAT3 as a plausible target for biliary repair during liver injury.
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